Symbicort Turbuhaler 30/60 Clinical Experience Investigation.

Trial Profile

Symbicort Turbuhaler 30/60 Clinical Experience Investigation.

Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2011

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Acronyms SURE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Dec 2011 Actual patient number is 3643 according to
    • 06 Dec 2011 Status changed from recruiting to completed as reported by
    • 13 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top